KMID : 1144820200260040310
|
|
´ëÇÑÀÇ»ý¸í°úÇÐȸÁö 2020 Volume.26 No. 4 p.310 ~ p.318
|
|
Ameliorative Potential of Rengyolone Against CCI-induced Neuropathic Pain in Rats
|
|
Lee Gil-Hyun
Hyun Kyung-Yae
|
|
Abstract
|
|
|
The sciatic nerve is the largest nerve among the peripheral nerves, and the damage to the sciatic nerve is caused by mechanical and physical pressure. This is an important disease that consumes a lot of time and money in the treatment process. Among them, research on relieving nerve pain caused by damage to the peripheral sciatic nerve has been made efforts to prevent and treat this disease through various methods such as drugs, natural products, electrical stimulation, exercise therapy, and massage. Existing treatments are not very effective in neurological pain, and countermeasures are needed. Forsythia Fructus, used in this study, has been used as a therapeutic agent for infectious diseases and a pain reliever for cancer from the past, and in past studies, it has been known to properly control the inflammatory response. In this study, rengyolone, a physiologically active substance of Forsythiae Fructus, was administered to rats that caused chronic left nerve pain to verify the pain relief effect. As a result of the experiment, it was found that mechanical pain and cold stimulation pain were significantly reduced in the rengyolone-treated group compared to the non-administered group. In addition, it was found that nerve growth factor (NGF) mRNA expression was significantly reduced and Cyclin-dependent kinase 2 (Cdc2) expression was increased in the rengyolone administration group. This increase in NGF expression is thought to be related to rengyolone's anti-inflammatory regulatory mechanism. It is expected that the reduced NGF was directly involved in pain relief.
|
|
KEYWORD
|
|
Forsythiae Fructus, Rengyolone, NGF, Cdc2, Animal behavior
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|